fda compounding semaglutide crackdown october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Intensifies Crackdown on GLP-1

More water = finer resolution Adding more solvent spreads the same peptide mass across more units

This enzyme normally breaks down incretin hormones, including the body's own GLP-1

Many standard supplements contain synthetic fillers, artificial colors, or flow agents like magnesium stearate that can cause unnecessary stress on the system

AOD-9604 is ideal for: Busy professionals in Mumbai seeking transformation without surgery Individuals with stubborn belly fat or postpartum weight Fitness buffs in their cutting phase People struggling with metabolic resistance Anyone wanting improved muscle tone and definition What Can You Expect

GLP-1 receptor agonists mimic a hormone your body already produces called glucagon-like peptide-1